[Nephrolithiasis in patients with intestinal diseases] - PubMed (original) (raw)
Review
. 2008 Jan-Feb;25(1):42-8.
[Article in Italian]
Affiliations
- PMID: 18264917
Review
[Nephrolithiasis in patients with intestinal diseases]
[Article in Italian]
M Cirillo et al. G Ital Nefrol. 2008 Jan-Feb.
Abstract
Intestinal diseases may cause the formation of urinary stones through changes in the metabolism of oxalate, calcium, and uric acid. The oxalate that is excreted into urine comes from the catabolism of ascorbic acid and some amino acids or from intestinal absorption of food oxalate. Calcium is absorbed by the gut after the stimulation of active vitamin D and is excreted by the kidney under the control of the bone/parathyroid hormone axis. Uric acid is generated by the oxidation of exogenous and endogenous purine bases, is excreted by the kidney through glomerular filtration/tubular secretion, and is soluble in alkaline urine. Several data indicate that patients with inflammatory bowel diseases are at high risk of urinary stones containing calcium-oxalate salt or uric acid. Calcium-oxalate stones are caused by colonic oxalate hyperabsorption (secondary to intestinal dysfunction) or by parenteral nutrition. Uric acid stones are typical of patients with severe diarrhea and/or intestinal neostomy, that is, in patients with hyperconcentrated acidic urine. Relationships between malabsorptive intestinal diseases and urinary stones are less well defined. Preventive countermeasures are not the same for all disorders. Hyperoxaluria should be controlled by diets with a low content of lipids and oxalate but supplemented with calcium and probiotics. The presence of hyperconcentrated acidic urine should be controlled by correct hydration and administration of citrate.
Similar articles
- Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.
Hesse A, Schneeberger W, Engfeld S, Von Unruh GE, Sauerbruch T. Hesse A, et al. J Am Soc Nephrol. 1999 Nov;10 Suppl 14:S329-33. J Am Soc Nephrol. 1999. PMID: 10541257 - Renal lithiasis and inflammatory bowel diseases, an update on pediatric population.
Bianchi L, Gaiani F, Bizzarri B, Minelli R, Cortegoso Valdivia P, Leandro G, Di Mario F, De' Angelis GL, Ruberto C. Bianchi L, et al. Acta Biomed. 2018 Dec 17;89(9-S):76-80. doi: 10.23750/abm.v89i9-S.7908. Acta Biomed. 2018. PMID: 30561398 Free PMC article. - Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
Terribile M, Capuano M, Cangiano G, Carnovale V, Ferrara P, Petrarulo M, Marangella M. Terribile M, et al. Nephrol Dial Transplant. 2006 Jul;21(7):1870-5. doi: 10.1093/ndt/gfl067. Epub 2006 Apr 4. Nephrol Dial Transplant. 2006. PMID: 16595587 - [Hyperoxaluria and renal calculi].
Buño Soto A, Torres Jiménez R, García Puig J, Mateos Antón F. Buño Soto A, et al. Arch Esp Urol. 1996 Sep;49(7):707-26. Arch Esp Urol. 1996. PMID: 9020008 Review. Spanish. - Enteric and mild hyperoxaluria.
Sutton RA, Walker VR. Sutton RA, et al. Miner Electrolyte Metab. 1994;20(6):352-60. Miner Electrolyte Metab. 1994. PMID: 7783697 Review.
Cited by
- Is There Such a Thing as "Anti-Nutrients"? A Narrative Review of Perceived Problematic Plant Compounds.
Petroski W, Minich DM. Petroski W, et al. Nutrients. 2020 Sep 24;12(10):2929. doi: 10.3390/nu12102929. Nutrients. 2020. PMID: 32987890 Free PMC article. Review. - Urolithiasis in complicated inflammatory bowel disease: a comprehensive analysis of urine profile and stone composition.
Torricelli FC, Reichard C, Monga M. Torricelli FC, et al. Int Urol Nephrol. 2021 Feb;53(2):205-209. doi: 10.1007/s11255-020-02649-x. Epub 2020 Sep 11. Int Urol Nephrol. 2021. PMID: 32915375 - Urolithiasis and crohn's disease.
Gaspar SR, Mendonça T, Oliveira P, Oliveira T, Dias J, Lopes T. Gaspar SR, et al. Urol Ann. 2016 Jul-Sep;8(3):297-304. doi: 10.4103/0974-7796.184879. Urol Ann. 2016. PMID: 27453651 Free PMC article. - Nephrolithiasis in patients with inflammatory bowel disease in the community.
Cury DB, Moss AC, Schor N. Cury DB, et al. Int J Nephrol Renovasc Dis. 2013 Jul 29;6:139-42. doi: 10.2147/IJNRD.S45466. Print 2013. Int J Nephrol Renovasc Dis. 2013. PMID: 23935383 Free PMC article. - Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles.
Theka T, Rodgers A, Ravenscroft N, Lewandowski S. Theka T, et al. Urolithiasis. 2013 Apr;41(2):111-7. doi: 10.1007/s00240-013-0543-1. Epub 2013 Jan 22. Urolithiasis. 2013. PMID: 23503872
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical